 |
| The European Commission and the FDA are fighting counterfeit medicines through traceability requirements in the pharmaceutical supply chain. |
Director Operations
CONCEPT HEIDELBERG GmbH
In 2011, the European Commission published Directive 2011/62/EC, the so-called Falsified Medicines Directive (or FMD).One goal was the fight against counterfeit medicines through serialization and verification. In 2014 the technical characteristics of these key ideas were defined, the unique identifier (UI), delivering the possibility of verification of the authenticity of single folding boxes. The unique identifier contains information on the:
- Manufacturer product code
- Serial Number
- National reimbursement number, if present
- Batch Number
- Expiry Date
READ MORE »